Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
11.9M
-
Shares change
-
+1.86M
-
Total reported value, excl. options
-
$297M
-
Value change
-
+$46.2M
-
Number of buys
-
44
-
Number of sells
-
-16
-
Price
-
$25.04
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q3 2018
68 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q3 2018.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.9M shares
of 53M outstanding shares and own 22.45% of the company stock.
Largest 10 shareholders include FMR LLC (3.19M shares), Polaris Venture Management Co. V, L.L.C. (2.55M shares), JENNISON ASSOCIATES LLC (798K shares), FRONTIER CAPITAL MANAGEMENT CO LLC (712K shares), Voya Investment Management LLC (491K shares), BlackRock Inc. (421K shares), Vanguard Group Inc (405K shares), Shannon River Fund Management LLC (396K shares), DISCOVERY CAPITAL MANAGEMENT, LLC / CT (320K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (300K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.